- 5 health systems shuttering ASCs
- Testosterone deficiency tied to up to $525B in healthcare costs
- Where US maternity care access stands in 2026
- 3 ASC closures in 1 week
- Could or should medical device representatives ever directly participate in surgical procedures? Opinion
- The $795M move turning Surgery Partners into a pure-play ASC operator
- 27 hospitals, health systems adding new C-suite roles in 2026
- ChristianaCare leader heads to Trinity Health
- 30 dental organizations among the fastest-growing US companies
- ‘Hospitals there are running out of options’: Nonprofit systems expand into Pennsylvania as for-profits exit
- Insurance industry losing jobs 4x faster than last year
- Court battles leaving the 340B program in legal limbo
- UM Health-Sparrow names 1st chaplain for community hospitals
- Ransomware breach at health IT vendor tops 3.8 million patients
- Illinois enacts law increasing oversight of private equity healthcare deals: 5 notes for dental leaders
- 51 behavioral health executive moves to know
- 5 data breaches in dentistry
- One-third of cardiologists are worth $5M or more: 10 things to know
- Rock Dental Brands partners with Florida specialty practice
- 3 Colorado practices accused of billing Medicare under deceased physician’s provider number
- ‘Feelings have no place’ in ASC expansion
- The ASC policy paradox
- 4 DSO giants getting bigger
- Kentucky nonprofit group to provide free surgeries to uninsured patients
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- 20 hospitals with the highest, lowest ED visit times for mental health patients
- Independent specialty practice joins McLeod Health
- The 1 word defining ASCs’ future: 42 leaders weigh in
- UVA psychiatry department names permanent chair after nearly a year as interim
- Maryland crisis center to lay off 62 after losing federal funding
- Henry Ford behavioral health pilot sees up to 85% drop in work queues after 1 year
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- The dental groups that will win the next wave of capital
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- CMS' mandatory VBC programs brought substantial administrative costs for hospitals: study
- Flagler Health secures $50M series B for AI-native MSK care platform expansion
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- Patients Wary of Governments, Companies Pushing AI as a Rural Healthcare Solution
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Rogers Behavioral Health opens 2 residential treatment centers
- 5 controversies in dentistry
- New York directs $21M to psychiatric emergency care
- Where dental school tuition is dropping
- Where dental school tuition is rising
- Why young dentists are flocking to DSOs
- DC’s use of opioid settlement funds for Medicaid draws supplantation complaints
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Trump signs executive order to overhaul pediatric vaccine recommendations
- New audit framework finds AI chatbots reinforce mental health risk patterns: Study
- Texas residential mental health center to add 16 beds
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- The number of health plans reporting operating losses is growing: report
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Bristol Myers Squibb lays out plan for $2.3B manufacturing facility in Houston
- Sanders, Cassidy request DOJ update on contempt status of former Steward Health Care CEO
- Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Quanterix hires GE Healthcare, Exact Sciences alum as chief commercial officer
- Same Knee Surgery, Twice the Price: Hospital Monopolies Push Up Healthcare Costs
- Many States Cover Doula Care, but Access to a ‘Birthing Bestie’ Is Often Out of Reach
- Doximity bets big on hospital adoption of enterprise AI as it ramps up tech spending
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Journalists Cover Cyclospora and Measles Outbreaks, and Changing Health Policies
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Industry Voices—AI won’t fix nurse burnout. Nurses will
- Therapy Dogs Aid Stroke Rehab
- Can Yoga Calm A Grumpy Gut?
- Insurers see positive results in managing health costs in Q2
- Lilly's Zepbound remains physicians' favorite, even as oral obesity launches alter landscape
- UPMC, KLAS Research study examines AI adoption trends, governance barriers
- The AI boom could boost Epic's position, health system execs say. Here's where AI startups can still win
- Review Finds Little Proof IVF Embryo Transfer Tricks Boost Success
- Short-Term Vegan Diet Linked To Lower Inflammation And Aging
- Novo Nordisk makes Omnicom agency of record for US media buying
- Fresenius Kabi recalls mislabeled morphine lot that could cause overdose death
- Medicaid Work Rule Leaves Homeless People In The Cold
- Wildfire Smoke An Increasing Hazard To U.S. Pregnancies, Study Says
- Watch: Why Abortions Are on the Rise Since ‘Roe’ Was Overturned
- Budget Battle Erupts in Nation’s Capital Over Opioid Settlement Money
- AbbVie’s Skyrizi retakes edge in pharma’s July ad spending league
- Verily Me, Bausch + Lomb visualize dry eye education in new collaboration
- Salmonella Outbreak Linked To Imported Jalapeños Sickens Hundreds
- UPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle
- Omada Health appoints Wei-Li Shao as new CEO as company ramps up GLP-1 strategy
- New bipartisan 340B reform bill curbs HHS' rebate pilot
- Inizio Engage expands medical information digs with Connected Insights platform
- Fierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat
- CCBHC model continues to expand, but faces some funding constraints
- Wildfire Smoke Sends More Oregonians To Emergency Rooms
- Weekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development
- Peanut Allergy? Fecal Transplant Might Be A Solution, Pilot Trial Finds
- New CDC Director Dr. Erica Schwartz Takes Over
- Three Midlife Habits That Could Help Protect Your Brain
- The Next Frontier in Patient Support: Connected Data, AI and Personalized Engagement
- Senate committee advances Fauci contempt referral; Schwartz confirmed as new CDC director
- Millie joins UCSF Health's clinically integrated network to coordinate maternity care
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Oscar Health hikes 2026 outlook after record profitability during first half of the year
- Takeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful
- Sarepta’s new CEO Michael Severino faces critical milestones to prove growth
- Germs From Pet Dogs Might Protect Infants Against Infection, Researchers Say
- Want Strong Bones? Review Says Vigorous Sports Like Handball Beat Walking, Strength Training
- Parenting Can Offset ADHD Risk In Toddlers, Study Says
- Nurses Chase Cyclospora, Aided By Interviews, Fast-Food Receipts — And The Messy Details
- Listen to the Latest ‘KFF Health News Minute’
- Medicaid Work Rule Leaves Homeless People in the Cold
- Watch: Democratic Senator Proposes a Fix for American Healthcare — Covering All Kids
- On the heels of star rating win, Clover Health boosts outlook on strength of MA membership growth in Q2
- ViiV rolls out long-acting HIV campaign targeting ‘future you’
- Fitch: 2025 likely 'a brief operational peak' for nonprofit hospitals ahead of OBBBA changes
- HHS announces decertification of Kentucky-based organ procurement organization Network for Hope
- Autism Therapy Spending Quintuples, Prompting Federal Push For State Oversight
- Could The Air You Breathe Be Triggering Painful Arthritis Flares?
- Childhood Obesity Might Impact Women's Future Ability To Give Birth
- AI-Managed Oxygen Promotes More Stable Oxygen Levels In Patients
- Maja Pedersen named president, taking reins of Fujifilm's CDMO as CEO role is retired
- Type 2 Diabetes Might Make Menopause Worse
- ‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
- AI Is Being Used To Boost Medicaid Enrollment, But Not Without Concerns
- Pesticides Linked To Increased ALS Risk, Review Finds
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Inside Doctronic’s AI prescription refill pilot program in Utah
- Michigan Reports First U.S. Deaths From Parasite Outbreak
- Fierce Healthcare Data Breach Tracker: Unlimited Technology Systems hack impacts 3M
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
Michigan healthcare freedom community forum
Sharyl Attkisson recently highlighted a public health fact many of us have long suspected. Without ever precisely saying so, she nails it in "The Clot Factor," her November 27, 2023 episode of Full Measure.
Public health is not the front line of healthcare.
It is, in fact, a backwater.
And despite their expertise, their regulatory power, their overweening ambitions, and their state and federal capture of American research dollars and Americans' health data, public health officials never will be anything but the backwater of healthcare.
Why?
Because they have lost the art of observing and treating individual patients, as such. The public health focus is population care, and especially when it comes to new disease, their passion for mass treatment blinds them to essential details.
The episode takes less than 11 minutes to watch.
https://www.youtube.com/watch?v=rnpccYly_J8
The front line of healthcare resides where it always has: with the individual clinician dedicated to observantly, intelligently, and conscientiously caring for individual patients.
And as she documents, front-line clinicians, freed of bureaucratic restraints, are more powerful for individual care than ever before.
America is long overdue for our state and federal health policies and spending to reflect this reality.
Washington Post explores the CDC's recently predicted (though not to be released until April) downward revision of COVID guidelines.
Unsurprisingly given this winter's non-event for COVID, the recommendations match what many in the private sector said 2-3 years ago.
As stated in the original post, public health IS the backwater of modern medicine. The full article includes audio, video, and additional images that are omitted here due to length.
https://www.washingtonpost.com/health/2024/02/13/covid-isolation-guidelines-cdc-change/
Any guesses on how long this "new advice" will take to wind through MDHHS and down to county health department standard operating procedures?
CDC plans to drop five-day covid isolation guidelines
February 13, 2024 at 6:00 a.m. EST CDC officials acknowledged in internal discussions and in a briefing last week with state health officials how much the covid-19 landscape has changed since the virus emerged four years ago, killing nearly 1.2 million people in the United States and shuttering businesses and schools. The new reality — with most people having developed a level of immunity to the virus because of prior infection or vaccination — warrants a shift to a more practical approach, experts and health officials say.“Public health has to be realistic,” said Michael T. Osterholm, an infectious-disease expert at the University of Minnesota. “In making recommendations to the public today, we have to try to get the most out of what people are willing to do. … You can be absolutely right in the science and yet accomplish nothing because no one will listen to you.”
The CDC plans to recommend that people who test positive for the coronavirus use clinical symptoms to determine when to end isolation. Under the new approach, people would no longer need to stay home if they have been fever-free for at least 24 hours without the aid of medication and their symptoms are mild and improving, according to three agency officials who spoke on the condition of anonymity to share internal discussions.
The federal recommendations follow similar moves by Oregon and California. The White House has yet to sign off on the guidance that the agency is expected to release in April for public feedback, officials said. One agency official said the timing could “move around a bit” until the guidance is finalized.
Work on revising isolation guidance has been underway since last August but was paused in the fall as covid cases rose. CDC director Mandy Cohen sent staff a memo in January that listed “Pan-resp guidance-April” as a bullet point for the agency’s 2024 priorities.Officials said they recognized the need to give the public more practical guidelines for covid-19, acknowledging that few people are following isolation guidance that hasn’t been updated since December 2021. Back then, health officials cut the recommended isolation period for people with asymptomatic coronavirus from 10 days to five because they worried essential services would be hobbled as the highly transmissible omicron variant sent infections surging. The decision was hailed by business groups and slammed by some union leaders and health experts.
The plan to further loosen isolation guidance when the science around infectiousness has not changed is likely to prompt strong negative reaction from vulnerable groups, including people older than 65, those with weak immune systems and long-covid patients, CDC officials and experts said.
Doing so “sweeps this serious illness under the rug,” said Lara Jirmanus, a clinical instructor at Harvard Medical School and a member of the People’s CDC, a coalition of health-care workers, scientists and advocates focused on reducing the harmful effects of covid-19.Public health officials should treat covid differently from other respiratory viruses, she said, because it’s deadlier than the flu and increases the risk of developing long-term complications. As many as 7 percent of Americans report having suffered from a slew of lingering covid symptoms, including fatigue, difficulty breathing, brain fog, joint pain and ongoing loss of taste and smell, according to the CDC.
While the coronavirus continues to cause serious illness, especially among the most vulnerable people, vaccines and effective treatments such as Paxlovid are available. The latest versions of coronavirus vaccines were 54 percent effective at preventing symptomatic infection in adults, according to data released Feb. 1, the first U.S. study to assess how well the shots work against the most recent coronavirus variant. But CDC data shows only 22 percent of adults and 12 percent of children had received the updated vaccine as of Feb. 9, despite data showing the vaccines provide robust protection against serious illness.Coronavirus levels in wastewater indicate that symptomatic and asymptomatic infections remain high. About 20,000 people are still hospitalized — and about 2,300 are dying — every week, CDC data show. But the numbers are falling and are much lower than when deaths peaked in January 2021 when almost 26,000 people died of covid each week and about 115,000 were hospitalized.
The lower rates of hospitalizations were among the reasons California shortened its five-day isolation recommendation last month, urging people to stay home until they are fever-free for 24 hours and their symptoms are mild and improving. Oregon made a similar move last May.
California’s state epidemiologist Erica Pan said the societal disruptions that resulted from strict isolation guidelines also helped spur the change. Workers without sick leave and those who can’t work from home if they or their children test positive and are required to isolate bore a disproportionate burden. Strict isolation requirements can act as a disincentive to test when testing should be encouraged so people at risk for serious illness can get treatment, she said.
Giving people symptom-based guidance, similar to what is already recommended for flu, is a better way to prioritize those most at risk and balance the potential for disruptive impacts on schools and workplaces, Pan said. After Oregon made its change, the state has not experienced any disproportionate increases in community transmission or severity, according to data shared last month with the national association representing state health officials.
California still recommends people with covid wear masks indoors when they are around others for 10 days after testing positive — even if they have no symptoms — or becoming sick. “You may remove your mask sooner than 10 days if you have two sequential negative tests at least one day apart,” the California guidance states.It’s not clear whether the updated CDC guidance will continue to recommend masking for 10 days.
Health officials from other states told the CDC last week that they are already moving toward isolation guidelines that would treat the coronavirus the same as flu and RSV, with additional precautions for people at high risk, said Anne Zink, an emergency room physician and Alaska’s chief medical officer.
Many other countries, including the United Kingdom, Denmark, Finland, Norway and Australia, made changes to isolation recommendations in 2022. Of 16 countries whose policies California officials reviewed, only Germany and Ireland still recommend isolation for five days, according to a presentation the California public health department gave health officials from other states in January. The Singapore ministry of health, in updated guidance late last year, said residents could “return to normal activities” once coronavirus symptoms resolve.
Even before the Biden administration ended the public health emergency last May, much of the public had moved on from covid-19, with many people having long given up testing and masking, much less isolating when they come down with covid symptoms.Doctors say the best way for sick people to protect their communities is to mask or avoid unnecessary trips outside the home.
“You see a lot of people with symptoms — you don’t know if they have covid or influenza or RSV — but in all three of those cases, they probably shouldn’t be at Target, coughing, and looking sick,” said Eli Perencevich, an internal medicine professor at the University of Iowa.
Lena H. Sun
Washington, D.C.
National reporter focusing on health
Education: Cornell University, BS in communication; Columbia University, MA in journalism
Lena H. Sun is a national reporter for The Washington Post covering health, with a special focus on public health and infectious disease. A longtime reporter at The Post, she has covered a variety of beats, including the Metro transit system, immigration and education. She has also served as The Post's Beijing bureau chief.
Honors and Awards: Pulitzer Prize for National Reporting for coverage of the war on terrorism, part of national reporting team, 2002; Robert F. Kennedy journalism award, international print, 1994
Professional Affiliations: Association of Health Care Journalists
Languages spoken in addition to English: Mandarin, some French, some Spanish
And here's your answer:over three months later, reporting hospital admissions is over.
From my county's weekly newsletter, dated May 22, 2024.
COVID-19 Hospital Admissions
Effective May 1, 2024, hospitals are no longer required to report COVID-19 hospital admissions, hospital capacity, or hospital occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The data will be archived as of May 10, 2024, and available at United States COVID-19 Hospitalization Metrics by Jurisdiction, Timeseries.
And here's your answer:over three months later, reporting hospital admissions is over.
From my county's weekly newsletter, dated May 22, 2024.
COVID-19 Hospital Admissions
Effective May 1, 2024, hospitals are no longer required to report COVID-19 hospital admissions, hospital capacity, or hospital occupancy data to HHS through CDC’s National Healthcare Safety Network (NHSN). The data will be archived as of May 10, 2024, and available at United States COVID-19 Hospitalization Metrics by Jurisdiction, Timeseries.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















